Terry Kohler

Insider Reports History

Entity
Individual
Location
C/O Verrica Pharmaceuticals Inc., 44 West Gay Street, Suite 400, West Chester, PA
Signature
/s/ Anthony J. Krick, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Terry Kohler:

Stock Role Class Num Shares Value Price $ Report Date Ownership
OptiNose, Inc. Chief Financial Officer Common Stock 150K $131K $0.87 Oct 7, 2024 Direct
Verrica Pharmaceuticals Inc. CHIEF FINANCIAL OFFICER Common Stock 44.7K $110K $2.46 Aug 27, 2024 Direct
OptiNose, Inc. Chief Financial Officer Stock Option (Right to Buy) 675K Oct 7, 2024 Direct
Verrica Pharmaceuticals Inc. CHIEF FINANCIAL OFFICER Employee Stock Option (right to buy) 80K Mar 15, 2024 Direct

Insider Reports Filed by Terry Kohler

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OPTN OptiNose, Inc. Oct 7, 2024 2 $0 4 Oct 7, 2024 Chief Financial Officer
OPTN OptiNose, Inc. Oct 7, 2024 0 $0 3 Oct 7, 2024 Chief Financial Officer
VRCA Verrica Pharmaceuticals Inc. Aug 26, 2024 2 -$77.5K 4 Aug 28, 2024 CHIEF FINANCIAL OFFICER
VRCA Verrica Pharmaceuticals Inc. Mar 15, 2024 2 $0 4 Mar 19, 2024 CHIEF FINANCIAL OFFICER
VRCA Verrica Pharmaceuticals Inc. Nov 14, 2023 2 -$82.7K 4 Nov 16, 2023 Chief Financial Officer
VRCA Verrica Pharmaceuticals Inc. Aug 24, 2023 1 $0 4 Aug 28, 2023 Chief Financial Officer
VRCA Verrica Pharmaceuticals Inc. Mar 1, 2023 1 $0 4 Mar 3, 2023 Chief Financial Officer
VRCA Verrica Pharmaceuticals Inc. Feb 24, 2022 1 $0 4 Feb 25, 2022 Chief Financial Officer
VRCA Verrica Pharmaceuticals Inc. Jul 16, 2021 1 $0 4 Jul 20, 2021 Chief Financial Officer
VRCA Verrica Pharmaceuticals Inc. Jul 16, 2021 0 $0 3 Jul 20, 2021 Chief Financial Officer